Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences in Plasma Redox Status and Leukocyte Activation
Nandan K. Mondal(University of Louisville), Zhongjun J. Wu(University of Maryland, Baltimore), Si M. Pham(WinnMed), Bartley P. Griffith(University of Maryland, Baltimore), Steven C. Koenig(University of Louisville), Erik N. Sorensen(University of Maryland, Baltimore), Mark S. Slaughter(University of Louisville)
Cited by 29
Related Papers
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
|The Lancet|1984|1.3k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711